Inventor · disambiguated record
Thomas M. Schmitt
Also filed as: SCHMITT THOMAS · SCHMITT THOMAS M
17 granted patents·13 pending applications·55 citations·filing 1985–2024
91Inventor score
Files withFRED HUTCHINSON CANCER CENTER13HUTCHINSON FRED CANCER RES10ADAPTIVE BIOTECHNOLOGIES CORP1AFFINI T THERAPEUTICS INC1BASF CORP1
Top patents by PatentIndex Score
30 records- 0188US11725210B2Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Aug 15, 2023·4 cites·22 claims
- 0285US11458191B2Binding proteins specific for RAS neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Oct 4, 2022·1 cites·30 claims
- 0385US11041202B2Method of identifying human compatible T cell receptors specific for an antigenic targetADAPTIVE BIOTECHNOLOGIES CORP·Filed 2016·Granted Jun 22, 2021·3 cites·16 claims
- 0485US11034748B2High affinity MAGE-A1-specific TCRs and uses thereofHUTCHINSON FRED CANCER RES·Filed 2019·Granted Jun 15, 2021·4 cites·30 claims
- 0584US12012443B2Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Jun 18, 2024·1 cites·16 claims
- 0684US11382954B2Binding proteins specific for RAS neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted Jul 12, 2022·1 cites·30 claims
- 0784US7575925B2Cell preparations comprising cells of the T cell lineage and methods of making and using themSUNNYBROOK HEALTH SCIENCES CT·Filed 2003·Granted Aug 18, 2009·21 cites·8 claims
- 0882US10538572B2T cell immunotherapy specific for WT-1HUTCHINSON FRED CANCER RES·Filed 2015·Granted Jan 21, 2020·5 cites·47 claims
- 0979US2025109180A1Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 1078US2025114433A1Binding proteins specific for ras neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 1176US11026969B2High affinity T cell receptors and uses thereofHUTCHINSON FRED CANCER RES·Filed 2016·Granted Jun 8, 2021·1 cites·17 claims
- 1271US12365906B2Immunomodulatory fusion proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2023·Granted Jul 22, 2025·0 cites·43 claims
- 1371US4647705AProcess for improving the ultraviolet light transmittance of ethylene glycolBASF CORP·Filed 1985·Granted Mar 3, 1987·10 cites·4 claims
- 1471US2023139737A1Binding proteins specific for ras neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 1570US10344075B2Engineered high-affinity human t cell receptorsUNIV ILLINOIS·Filed 2014·Granted Jul 9, 2019·0 cites·13 claims
- 1664US2025177531A1Binding proteins specific for ras neoantigens and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 1761US2025152717A1Binding proteins and engineered cells specific for neoantigens and uses thereofAFFINI T THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1859US10875904B2Enhanced affinity T cell receptors and methods for making the sameHUTCHINSON FRED CANCER RES·Filed 2017·Granted Dec 29, 2020·0 cites·33 claims
- 1957US2021355189A1High affinity mage-a1-specific tcrs and uses thereofHUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 2056US2024209058A1Mesothelin-specific T cell Receptors and Methods of Using SameUNIV MINNESOTA·Filed 2022·Application pending·0 cites
- 2155US2025032540A1Compositions and methods for cellular immunotherapyFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 2254US2025018036A1Immunotherapy targeting sox2 antigensFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 2351US9751928B2Enhanced affinity T cell receptors and methods for making the sameHUTCHINSON FRED CANCER RES·Filed 2013·Granted Sep 5, 2017·0 cites·20 claims
- 2450US12448430B2High avidity WT1 T cell receptors and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2020·Granted Oct 21, 2025·0 cites·49 claims
- 2550US2022409661A1T-cell immunotherapy specific for wt-1HUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 2647US4575559AProcess for preparing certain sulfophenethylsiloxanesBASF WYANDOTTE CORP·Filed 1985·Granted Mar 11, 1986·4 cites·11 claims
- 2746US2018044404A1Immunomodulatory fusion proteins and uses thereofHUTCHINSON FRED CANCER RES·Filed 2016·Application pending·0 cites
- 2843US11534461B2High affinity merkel cell polyomavirus T antigen-specific TCRS and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2017·Granted Dec 27, 2022·0 cites·37 claims
- 2943US2021252057A1Merkel cell polyomavirus t antigen-specific tcrs and uses thereofHUTCHINSON FRED CANCER RES·Filed 2019·Application pending·0 cites
- 3037US2019127435A1Immunomodulatory il2r fusion proteins and uses thereofHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas M. Schmitt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →